生殖计划:长效可逆避孕药和紧急避孕药。

Q3 Medicine FP essentials Pub Date : 2024-03-01
Samantha Glass, Megan L Wilson, Emily M Godfrey, Ying Zhang
{"title":"生殖计划:长效可逆避孕药和紧急避孕药。","authors":"Samantha Glass, Megan L Wilson, Emily M Godfrey, Ying Zhang","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Long-acting reversible contraceptives (LARCs) include progestin and copper intrauterine devices (IUDs) and progestin subdermal implants. LARCs may be the preferred for individuals who want a method that is highly effective and can last for several years, or for whom estrogen is contraindicated. LARCs should be offered using a shared decision-making approach, keeping in mind that historically these methods have been used coercively to control the reproductive choices of marginalized or disabled people. To ensure safe prescribing and reduce barriers to receiving LARCs, family physicians should be familiar with two evidence-based national contraceptive guidelines: the <i>U.S. Medical Eligibility Criteria for Contraceptive Use</i> (U.S. MEC) and the <i>U.S. Selected Practice Recommendations for Contraceptive Use</i> (U.S. SPR). Information about insertion, removal, potential complications, and expected adverse effects should be included when counseling patients about LARC options. Both types of LARC IUDs can safely be used for emergency contraception if inserted within 5 days of unprotected intercourse. Several oral emergency contraception drug options also are available.</p>","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"538 ","pages":"25-29"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reproductive Planning: Long-Acting Reversible Contraceptives and Emergency Contraception.\",\"authors\":\"Samantha Glass, Megan L Wilson, Emily M Godfrey, Ying Zhang\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Long-acting reversible contraceptives (LARCs) include progestin and copper intrauterine devices (IUDs) and progestin subdermal implants. LARCs may be the preferred for individuals who want a method that is highly effective and can last for several years, or for whom estrogen is contraindicated. LARCs should be offered using a shared decision-making approach, keeping in mind that historically these methods have been used coercively to control the reproductive choices of marginalized or disabled people. To ensure safe prescribing and reduce barriers to receiving LARCs, family physicians should be familiar with two evidence-based national contraceptive guidelines: the <i>U.S. Medical Eligibility Criteria for Contraceptive Use</i> (U.S. MEC) and the <i>U.S. Selected Practice Recommendations for Contraceptive Use</i> (U.S. SPR). Information about insertion, removal, potential complications, and expected adverse effects should be included when counseling patients about LARC options. Both types of LARC IUDs can safely be used for emergency contraception if inserted within 5 days of unprotected intercourse. Several oral emergency contraception drug options also are available.</p>\",\"PeriodicalId\":38325,\"journal\":{\"name\":\"FP essentials\",\"volume\":\"538 \",\"pages\":\"25-29\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"FP essentials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"FP essentials","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

长效可逆避孕药(LARCs)包括孕激素和铜宫内节育器(IUDs)以及孕激素皮下埋植剂。长效可逆避孕药可能是那些想要一种高效且可持续数年的避孕方法,或对雌激素有禁忌症的人的首选。在提供 LARCs 时,应采用共同决策的方法,同时牢记这些方法在历史上曾被用来强制控制边缘化人群或残疾人的生育选择。为确保安全处方并减少接受 LARCs 的障碍,家庭医生应熟悉两份以证据为基础的国家避孕指南:《美国避孕药具使用医疗资格标准》(U.S. MEC)和《美国避孕药具使用实践建议选编》(U.S. SPR)。在向患者提供有关 LARC 选择的咨询时,应包括有关插入、取出、潜在并发症和预期不良反应的信息。如果在无保护性交后 5 天内放置 LARC 宫内节育器,两种类型的宫内节育器都可以安全地用于紧急避孕。此外,还有多种口服紧急避孕药物可供选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Reproductive Planning: Long-Acting Reversible Contraceptives and Emergency Contraception.

Long-acting reversible contraceptives (LARCs) include progestin and copper intrauterine devices (IUDs) and progestin subdermal implants. LARCs may be the preferred for individuals who want a method that is highly effective and can last for several years, or for whom estrogen is contraindicated. LARCs should be offered using a shared decision-making approach, keeping in mind that historically these methods have been used coercively to control the reproductive choices of marginalized or disabled people. To ensure safe prescribing and reduce barriers to receiving LARCs, family physicians should be familiar with two evidence-based national contraceptive guidelines: the U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) and the U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR). Information about insertion, removal, potential complications, and expected adverse effects should be included when counseling patients about LARC options. Both types of LARC IUDs can safely be used for emergency contraception if inserted within 5 days of unprotected intercourse. Several oral emergency contraception drug options also are available.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
FP essentials
FP essentials Medicine-Medicine (all)
CiteScore
1.00
自引率
0.00%
发文量
58
期刊最新文献
Female Pelvic Conditions: Dyspareunia and Vulvodynia. Female Pelvic Conditions: Foreword. Female Pelvic Conditions: Interstitial Cystitis/Bladder Pain Syndrome. Female Pelvic Conditions: Sexually Transmitted Infections. Female Pelvic Conditions: Urinary Incontinence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1